Matthew Simas - Magellan Health Director

Director

Mr. Matthew J. Simas is no longer Director of the Company with effective May 2019. Simas currently serves as the director of Truveris, Inc., a private healthcare services company providing transparency to the prescription drug ecosystem through datadriven innovations. He has 30 years of experience in the healthcare industry with extensive expertise in health technology and in the pharmacy benefits management industry. Simas was founder, chairman and chief executive officer of MedInitiatives, Inc., a provider of business intelligence technology and data analytics serving the pharmacy benefit manager, payer and pharma markets, which was acquired by IMS Health in 2007. He also held previous roles as a director of MedImpact Healthcare Systems, Inc., and the executive chairman of BusinessOne Technologies, Inc. Simas also served as the chairman and interim chief executive officer of Alliance Health, a private healthcare company providing services to members with chronic health conditions. since 2018.
Age 52
Tenure 6 years
Phone800 642-1716
Webwww.magellanhealth.com

Magellan Health Management Efficiency

The company has return on total asset (ROA) of 0.54 % which means that it generated a profit of $0.54 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.16) %, meaning that it created substantial loss on money invested by shareholders. Magellan Health's management efficiency ratios could be used to measure how well Magellan Health manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 562.64 M in liabilities with Debt to Equity (D/E) ratio of 0.28, which may suggest the company is not taking enough advantage from borrowing. Magellan Health has a current ratio of 2.86, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Magellan Health until it has trouble settling it off, either with new capital or with free cash flow. So, Magellan Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Magellan Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Magellan to invest in growth at high rates of return. When we think about Magellan Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Robert IsraelWT Offshore
64
Michael YatesAinsworth Game Technology
63
Jerome DavisGameStop Corp
63
James GrubeGameStop Corp
49
Steven KooninGameStop Corp
60
Lizabeth DunnGameStop Corp
45
Jack EugsterBlack Hills
69
John VeringBlack Hills
71
Shane KimGameStop Corp
54
Carmen RomeoSEI Investments
73
Thomas ZellerBlack Hills
70
Lawrence ZilavyGameStop Corp
67
Alexander WhitelamSEI Investments
N/A
Mark SchoberBlack Hills
65
Frank StanleyWT Offshore
63
Richard LiebSEI Investments
66
James NelsonWT Offshore
75
Stephanie ShernGameStop Corp
69
Richard FontaineGameStop Corp
72
Teresa TaylorBlack Hills
57
Carl GuarinoSEI Investments
60
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation. Magellan Health operates under Healthcare Plans classification in the United States and is traded on NASDAQ Exchange. It employs 9000 people. Magellan Health (MGLN) is traded on NASDAQ Exchange in USA and employs 9,000 people.

Management Performance

Magellan Health Leadership Team

Elected by the shareholders, the Magellan Health's board of directors comprises two types of representatives: Magellan Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Magellan. The board's role is to monitor Magellan Health's management team and ensure that shareholders' interests are well served. Magellan Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Magellan Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Eran Broshy, Independent Director
Swati Abbott, Director
Mostafa Kamal, Senior Vice President and General Manager
Scott MacKenzie, Independent Director
Barry Smith, Chairman and CEO
Mary Sammons, Independent Director
Joe Bogdan, Senior Vice President Corporate Finance
Steven Shulman, Independent Director
Matthew Simas, Director
Perry Fine, Independent Director
Daniel Gregoire, General Counsel and Secretary
Kay James, Director
Srinivas Koushik, CTO
Leslie Norwalk, Independent Director
John Agwunobi, Independent Director
John Littel, Senior Vice President - Government Affairs and Communications
Michael Diament, Independent Director
William McBride, Independent Director
Guy Sansone, Independent Director
Peter Feld, Independent Director
Renie Shapiro, Senior Vice President Corporate Finance
Michael Ressner, Independent Director
Sanjeev Srivastava, CEO of Magellan Healthcare
Caskie LewisClapper, Chief Human Resource Officer

Magellan Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Magellan Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Magellan Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Magellan Health's short interest history, or implied volatility extrapolated from Magellan Health options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in Magellan Stock

If you are still planning to invest in Magellan Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Magellan Health's history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules